-
Views
-
Cite
Cite
Michaela Rancea, Andrea Will, Peter Borchmann, Ina Monsef, Andreas Engert, Nicole Skoetz, Fifteenth Biannual Report of the Cochrane Haematological Malignancies Group—Focus on Non-Hodgkin’s Lymphoma, JNCI: Journal of the National Cancer Institute, Volume 105, Issue 15, 7 August 2013, Pages 1159–1170, https://doi.org/10.1093/jnci/djt165
- Share Icon Share
Abstract
This fifteenth biannual report of the Cochrane Haematological Malignancies Group (CHMG) highlights recently published randomized controlled trials (RCTs) in the field of hemato-oncology, covering the publication period from October 2011 to May 2012. Implications for clinical practice and methodological aspects are the main principles for selecting trials for this report. Studies were identified by electronic search of MEDLINE using a broad search filter that covers all topics in hemato-oncology combined with a highly sensitive search filter for randomized trials ( Cochrane Handbook for Systematic Reviews of Interventions ).
- radiation therapy
- chemotherapy regimen
- follow-up
- hematologic neoplasms
- diffuse large b-cell lymphoma
- lymphoma, non-hodgkin
- medical oncology
- medline
- platelet transfusion
- safety
- multiple myeloma
- arm
- rituximab
- autologous stem cell transplant
- toxic effect
- cyclophosphamide, doxorubicin, prednisone, and vincristine
- filters
- indolent